Drug-induced Q-T prolongation

Research output: Contribution to journalReview articlepeer-review

33 Scopus citations


Drug therapy may induce Q-T prolongation by alteration of potassiumion currents in cardiac cells, resulting in abnormal repolarization. Q-T prolongation, whether congenital or acquired, has been associated with the development of the malignant dysrhythmia Torsade de Pointes (TdP), which may result in sudden death. Recent regulatory actions and drug withdrawals due to Q-T prolongation or TdP have focused attention on this issue. Although our understanding of the pathophysiology continues to evolve, both patient and medication factors contribute to the individual risk of drug-induced Q-T prolongation or TdP. The clinician should be aware of these issues when prescribing new drugs and should weigh the risks and benefits carefully when prescribing drugs known to prolong the Q-T interval.

Original languageEnglish (US)
Pages (from-to)1125-1144
Number of pages20
JournalMedical Clinics of North America
Issue number6
StatePublished - Nov 1 2005

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Drug-induced Q-T prolongation'. Together they form a unique fingerprint.

Cite this